Thialean Pwr For Inj USP 1 g / 5 g Powder For Solution is a Health Canada–registered veterinary drug (DIN 00620823) held by Mtc Pharmaceuticals, containing Thiamylal Sodium. Health Canada lists its status as Cancelled Post Market (status date 02 Sep 1998). Nexara Health has matched 9 registrations of Thiamylal Sodium across 1 other regulated market.
Health Canada registration
| DIN | 00620823 |
|---|---|
| Brand name | Thialean Pwr For Inj USP |
| Active ingredient | Thiamylal Sodium |
| Strength | 1 g / 5 g |
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Company | Mtc Pharmaceuticals |
| Status | Cancelled Post Market — 02 Sep 1998 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Thiamylal Sodium registered in other markets
9 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Citosol For Injection 0.3gm (I.v.) | Kyorin Pharmaceutical Co. Ltd. | 乾粉注射劑 | 已註銷 | TFDA | |
| Taiwan | Citosol For Injection 0.5gm (I.v.) | Kyorin Pharmaceutical Co. Ltd. | 乾粉注射劑 | 已註銷 | TFDA | |
| Taiwan | Citosol Injection 0.3gm | Kyorin Pharmaceutical Co. Ltd. | 乾粉注射劑 | 已註銷 | TFDA | |
| Taiwan | Citosol Injection 0.5gm | Kyorin Pharmaceutical Co. Ltd. | 乾粉注射劑 | 已註銷 | TFDA | |
| Taiwan | Citosol Injection 300mg | 杏林新生製藥股份有限公司 | 凍晶注射劑 | Registered | TFDA | |
| Taiwan | Citosol Injection 500mg | 杏林新生製藥股份有限公司 | 凍晶注射劑 | Registered | TFDA | |
| Taiwan | Isozol 0.3gm | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 乾粉注射劑 | 已註銷 | TFDA | |
| Taiwan | Isozol 0.5gm | Welifide Corporation(Welfide Corporation Yoshitomi Factory) | 乾粉注射劑 | 已註銷 | TFDA |
See every manufacturer of Thiamylal Sodium worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Thialean Pwr For Inj USP (DIN 00620823) marketed in Canada?
No. Health Canada lists DIN 00620823 as Cancelled Post Market as of 02 Sep 1998.
Who holds the Canadian licence for this product?
Mtc Pharmaceuticals is the company of record in the Health Canada Drug Product Database.
Is Thiamylal Sodium registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00620823, status date 1998-09-02; national medicine registries: TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00620823, status date 1998-09-02; national medicine registries: TFDA.
Health Canada Drug Product Database (DPD), DIN 00620823, status date 1998-09-02; national medicine registries: TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.